Validity, Significance, Strengths, Limitations, and Evidentiary Value of Real-World Clinical Data for Combination Therapy in Alzheimer’s Disease: Comparison of Efficacy and Effectiveness Studies

Publisher： Karger

E-ISSN： 1660-2862|10|1-4|170-174

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.10, Iss.1-4, 2012-02, pp. : 170-174

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alzheimer’s as a metabolic disease

By Demetrius Lloyd   Driver Jane  

Biogerontology, Vol. 14, Iss. 6, 2013-12 ,pp. : 641-649

Springer Publishing Company

Access to resources Recommend Favorite

Retromers in Alzheimer’s Disease

By  

Neurodegenerative Diseases, Vol. 10, Iss. 1-4, 2012-03 ,pp. : 116-121

Karger

Access to resources Recommend Favorite

α-Secretase Activation – An Approach to Alzheimer’s Disease Therapy

By  

Neurodegenerative Diseases, Vol. 3, Iss. 4-5, 2006-10 ,pp. : 255-261

Karger

Access to resources Recommend Favorite

Autophagy Dysfunction in Alzheimer’s Disease

By  

Neurodegenerative Diseases, Vol. 7, Iss. 4, 2010-05 ,pp. : 265-271

Karger

Access to resources Recommend Favorite

The Incidence and Prevalence of Alzheimer’s Disease

By  

Neurodegenerative Diseases, Vol. 8, Iss. 1-2, 2010-08 ,pp. : 9-14

Karger

Access to resources Recommend Favorite